The presentation by Dr. Dirk Beher, Chief Executive Officer of FundaMental Pharma, will highlight the scientific foundation for lead candidate FMP374, the distinctive approach to modulating NMDAR, and ...

How organizations handle disagreement shapes not only their internal health, but also the civic capacities society depends on ...

Clay brings a distinguished track record in global project delivery and site relationship strategy. He has led large-scale ...

President Abdel-Fattah El-Sisi said Africa had advanced financing and institutional reforms under Agenda 2063 during his ...

Backed by a leading Dallas-Fort Worth private equity fund, Prime Power combines 50+ years of energy expertise across natural gas, wind, solar, and BESS to address surging demand for ...

The government has unveiled a new development plan, committing KSh 400 billion annually to support four key infrastructure ...

From antibiotic resistance to emerging viral threats, the global demand for new medicines is intensifying, yet traditional drug discovery pipelines remain slow and expensive. A new scientific review ...

WARREN, ID / ACCESS Newswire / February 18, 2026 / Sidney Resources Corporation (OTCID:SDRC) ("Sidney" or the "Company") today outlined its strategic priorities and operational objectives for 2026, re ...

CD Bioparticles launches comprehensive OMV-Based Bacterial Vaccines Development services for infectious disease and ...

ZHENGZHOU, HENAN, CHINA, January 21, 2026 /EINPresswire.com/ -- The global agricultural sector is experiencing a period ...

Economic developers, business leaders, and policymakers convene to shape the future of the Great Lakes economy.

Eradivir Inc., the leading clinical-stage biotech company developing antibody recruiting small molecules to treat disease, today announced EV148 as its development candidate for the treatment of ...